- Home
- ESLA vs GECC Comparison
ESLA vs GECC Comparison
Compare ESLA & GECC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | ESLA | GECC |
|---|---|---|
| Founded | 2021 | 2016 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Finance: Consumer Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 60.9M | 69.0M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | ESLA | GECC |
|---|---|---|
| Price | $1.06 | $5.08 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 1 | 2 |
| Target Price | $8.00 | ★ $10.75 |
| AVG Volume (30 Days) | 45.7K | ★ 140.9K |
| Earning Date | 03-18-2026 | 03-02-2026 |
| Dividend Yield | N/A | ★ 24.39% |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $0.92 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.76 | $4.63 |
| 52 Week High | $3.15 | $11.45 |
Technical Indicators
Market Signals| Indicator | ESLA | GECC |
|---|---|---|
| Relative Strength Index (RSI) | 41.56 | 38.60 |
| Support Level | $1.01 | $4.63 |
| Resistance Level | $1.35 | $7.07 |
| Average True Range (ATR) | 0.11 | 0.23 |
| MACD | -0.00 | 0.04 |
| Stochastic Oscillator | 14.04 | 44.26 |
Price Performance
Historical ComparisonAbout ESLA Estrella Immunopharma Inc.
Estrella Immunopharma Inc is a clinical-stage biopharmaceutical company developing CD19 and CD22-targeted ARTEMIS T-cell therapies with the capacity to address treatment challenges for patients with blood cancers and solid tumors. Estrella's mission is to harness the evolutionary power of the human immune system to transform the lives of patients fighting cancer and autoimmune diseases.
About GECC Great Elm Capital Corp.
Great Elm Capital Corp is an externally managed, non-diversified closed-end management investment company. It generates both income and capital appreciation through debt and income-generating equity investments, including investments in finance businesses. The Company operates as a single reportable segment with an investment objective to generate both current income and capital appreciation through debt and equity investments and manages the business on a consolidated basis.